0 Σχόλια
0 Μοιράστηκε
64 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Kirsten Rat Sarcoma (KRAS) Market – Oncology Breakthroughs & Targeted Therapy Outlook"Future of Executive Summary Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market research report is a sure solution to get market insights with which...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has incorporated...0 Σχόλια 0 Μοιράστηκε 956 Views 0 Προεπισκόπηση
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Σχόλια 0 Μοιράστηκε 512 Views 0 Προεπισκόπηση
-
Cell Cycle Inhibitors Market Advancing Targeted Cancer TreatmentsIn-Depth Study on Executive Summary Cell Cycle Inhibitors Market Size and Share CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. This Cell Cycle Inhibitors Market report is structured with the thorough market analysis carried...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Σχόλια 0 Μοιράστηκε 497 Views 0 Προεπισκόπηση
-
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Σχόλια 0 Μοιράστηκε 340 Views 0 Προεπισκόπηση
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Σχόλια 0 Μοιράστηκε 407 Views 0 Προεπισκόπηση
-
High Potent Pharmaceuticals Product Market Analysis 2025–2031: CAGR Growth, Trends & Future OutlookHigh Potent Pharmaceutical Products are drugs that possess high therapeutic potency and can produce desired medical effects at very low concentrations. These products require strict regulatory compliance and safety protocols. They are widely used in advanced pharmaceutical research and specialized medical treatments. High Potent Pharmaceuticals Product Market Analysis and Industry...0 Σχόλια 0 Μοιράστηκε 550 Views 0 Προεπισκόπηση
-
How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...0 Σχόλια 0 Μοιράστηκε 661 Views 0 Προεπισκόπηση
-
How Are Treatments Advancing in Metastatic Solid Tumors Market?Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...0 Σχόλια 0 Μοιράστηκε 365 Views 0 Προεπισκόπηση
-
Mantle Cell Lymphoma Therapeutics Market Set for Strong Growth Through 2034The global healthcare and oncology sectors are witnessing rapid advancements in cancer therapeutics, particularly in the treatment of rare and aggressive blood cancers such as mantle cell lymphoma (MCL). Increasing awareness regarding early diagnosis, advancements in targeted therapies, and growing investments in oncology research are significantly contributing to industry expansion. The rising...0 Σχόλια 0 Μοιράστηκε 305 Views 0 Προεπισκόπηση
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Σχόλια 0 Μοιράστηκε 441 Views 0 Προεπισκόπηση
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Σχόλια 0 Μοιράστηκε 66 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)